Sector revisions Alivus Life Sciences Limited

Equities

Market Closed - NSE India S.E. Other stock markets 05:19:44 16/12/2025 pm IST			5-day change	1st Jan Change
911.75 ^INR	+0.10%		+6.01%	-7.29%

25/11	Alivus Life Sciences Limited, Q2 2026 Earnings Call, Nov 07, 2025
07/11	Alivus Life Sciences Limited Reaffirms Earnings Guidance for the Fiscal Year 2026	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ALIVUS LIFE SCIENCES LIMITED							3
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							24
	ABBVIE INC.							28
	ROCHE HOLDING AG							18
	ASTRAZENECA PLC							19
	NOVARTIS AG							19
	MERCK & CO., INC.							26
	NOVO NORDISK A/S							20
	AMGEN INC.							27
	GILEAD SCIENCES, INC.							26
	PFIZER INC.							24
	SANOFI							21
	VERTEX PHARMACEUTICALS INCORPORATED							25
	BRISTOL-MYERS SQUIBB COMPANY							22
	GSK PLC							18
	CHUGAI PHARMACEUTICAL CO., LTD.							14
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							18
	ALNYLAM PHARMACEUTICALS, INC.							24
	Average							21
	Weighted average by Cap.							23